Sunniva Inc Announces Q3 2019 Financial Results And Dispute Related To Cathedral City Glasshouse.

VANCOUVER, British Columbia: Sunniva Inc. ("Sunniva", the "Company", "we", "our" or "us") (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and services, today released its financial results and management's discussion and analysis for the three and nine months ended September 30, 2019. All figures are reported in Canadian dollars ($), unless otherwise indicated. Sunniva's financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS"). The Company also reports receipt of a 30-day notice of termination under its build to suit lease for the Cathedral City Glasshouse and notices of default regarding funding of the facility.

"While the third quarter saw further progress with the construction of the Cathedral City Glasshouse as we move towards its completion, significant cost overruns have resulted in delays in payments and disputes over responsibility to cover construction costs. Sunniva has already funded over US $22 million in tenant improvements. A dispute about additional payments required to complete construction has prompted our lessor to give us a 30-day notice of termination and default under our build to suit agreement. We intend to vigorously defend our rights under the agreement," said Dr. Anthony Holler, CEO, Sunniva. "We continue to work towards finalizing the sale of Natural Health Services Ltd. and completion of the disposition of Sunniva Medical Inc., and the property at Okanagan Falls. While our principal focus is on completing these transformational corporate objectives, we have been successful in growing revenues from our existing businesses which year to date have exceeded our 2018 total revenue."

"If the Natural Health Services and Sunniva Medical Inc. transactions are completed, we will have achieved our transition to a pure play cannabis company in California," said Holler. "Sunniva is unwavering in our pursuit of our vertical integration strategy and the large scale, high-quality flower production from the world-class glasshouse will provide supply our extraction facility and will enable us to continue the development of our flower and concentrate brands and distribution businesses."

Financial Highlights - Three and nine months ended September 30, 2019

Consolidated Financial Highlights expressed in 000's of CAD$, except per share amounts

Three Months Ended September 30,

2019

2018

Change

Revenue

$ 5,361

$ 1,182

$ 4,179

Cost of Goods Sold

3,788

968

2,820

Gross Margin

1,573

214

1,359

Selling, General and Administrative

6,545

4,543

2,002

Production Facility Costs

1,262

-

1,262

Share-based Payments

293

2,303

(2,010)

Amortization Expense

612

251

361

Loss from Continuing Operations

(7,139)

(6,883)

(256)

Net Loss

$ (20,462)

$ (6,781)

$ (13,681)

Basic Loss Per Share

$ (0.52)

$ (0.21)

$ (0.31)

Weighted Average Number of Shares

39,174,040

32,042,054

7,131,986

Nine Months Ended September 30,

2019

2018

Change

Revenue

$ 21,228

$ 4,980

$ 16,248

Cost of Goods Sold

15,942

4,171

11,771

Gross Margin

5,286

809

4,477

Selling, General and Administrative

18,518

10,788

7,730

Production Facility Costs

3,051

-

3,051

Share-based Payments

1,821

6,408

(4,587)

Amortization Expense

1,763

678

1,085

...